Melatonin controls cell proliferation and modulates mitochondrial physiology in pancreatic stellate cells.


Journal

Journal of physiology and biochemistry
ISSN: 1877-8755
Titre abrégé: J Physiol Biochem
Pays: Spain
ID NLM: 9812509

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 04 06 2022
accepted: 21 10 2022
pubmed: 6 11 2022
medline: 10 2 2023
entrez: 5 11 2022
Statut: ppublish

Résumé

We have investigated the effects of melatonin on major pathways related with cellular proliferation and energetic metabolism in pancreatic stellate cells. In the presence of melatonin (1 mM, 100 µM, 10 µM, or 1 µM), decreases in the phosphorylation of c-Jun N-terminal kinase and of p44/42 and an increase in the phosphorylation of p38 were observed. Cell viability dropped in the presence of melatonin. A rise in the phosphorylation of AMP-activated protein kinase was detected in the presence of 1 mM and 100 µM melatonin. Treatment with 1 mM melatonin decreased the phosphorylation of protein kinase B, whereas 100 µM and 10 µM melatonin increased its phosphorylation. An increase in the generation of mitochondrial reactive oxygen species and a decrease of mitochondrial membrane potential were noted following melatonin treatment. Basal and maximal respiration, ATP production by oxidative phosphorylation, spare capacity, and proton leak dropped in the presence of melatonin. The expression of complex I of the mitochondrial respiratory chain was augmented in the presence of melatonin. Conversely, in the presence of 1 mM melatonin, decreases in the expression of mitofusins 1 and 2 were detected. The glycolysis and the glycolytic capacity were diminished in cells treated with 1 mM or 100 µM melatonin. Increases in the expression of phosphofructokinase-1 and lactate dehydrogenase were noted in cells incubated with 100 µM, 10 µM, or 1 µM melatonin. The expression of glucose transporter 1 was increased in cells incubated with 10 µM or 1 µM melatonin. Conversely, 1 mM melatonin decreased the expression of all three proteins. Our results suggest that melatonin, at pharmacological concentrations, might modulate mitochondrial physiology and energy metabolism in addition to major pathways involved in pancreatic stellate cell proliferation.

Identifiants

pubmed: 36334253
doi: 10.1007/s13105-022-00930-4
pii: 10.1007/s13105-022-00930-4
pmc: PMC9905253
doi:

Substances chimiques

Melatonin JL5DK93RCL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-249

Informations de copyright

© 2022. The Author(s).

Références

Gut. 2013 Sep;62(9):1328-39
pubmed: 23172890
J Physiol Biochem. 2019 Jun;75(2):185-197
pubmed: 30868511
Molecules. 2021 Aug 20;26(16):
pubmed: 34443626
Am J Physiol Cell Physiol. 2001 Jan;280(1):C110-8
pubmed: 11121382
Crit Rev Food Sci Nutr. 2019;59(1):133-140
pubmed: 28799779
Cell Mol Life Sci. 2014 Aug;71(16):2997-3025
pubmed: 24554058
J Pineal Res. 2022 Jan;72(1):e12779
pubmed: 34826168
Oncol Lett. 2019 Feb;17(2):1635-1645
pubmed: 30675223
J Microbiol Biotechnol. 2021 Dec 28;31(12):1615-1623
pubmed: 34528917
Front Cell Dev Biol. 2020 Sep 22;8:572182
pubmed: 33072754
Pancreas. 2004 Oct;29(3):179-87
pubmed: 15367883
Science. 2012 Aug 24;337(6097):975-80
pubmed: 22923583
FEBS Open Bio. 2020 Aug;10(8):1655-1667
pubmed: 32594651
Pancreas. 2004 Mar;28(2):153-9
pubmed: 15028947
Pancreas. 2020 Feb;49(2):273-280
pubmed: 32011531
Aging Cell. 2022 Nov;21(11):e13710
pubmed: 36088658
Free Radic Biol Med. 2015 Oct;87:226-36
pubmed: 26163001
Front Physiol. 2013 Nov 01;4:318
pubmed: 24198790
Sci Rep. 2020 Apr 14;10(1):6352
pubmed: 32286500
Cancers (Basel). 2020 Jun 21;12(6):
pubmed: 32575867
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Biol Cell. 2020 Oct;112(10):280-299
pubmed: 32632968
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188356
pubmed: 32147542
Cell Biol Toxicol. 2015 Apr;31(2):95-110
pubmed: 25764371
J Physiol Biochem. 2020 May;76(2):345-355
pubmed: 32361979
Pancreas. 2021 Apr 1;50(4):524-528
pubmed: 33939664
Gastroenterology. 1998 Aug;115(2):421-32
pubmed: 9679048
Life Sci. 2022 Jul 15;301:120612
pubmed: 35523285
J Physiol Biochem. 2013 Dec;69(4):897-908
pubmed: 23904230
Toxicol Lett. 2014 Sep 17;229(3):465-73
pubmed: 25068500
Mol Biol Rep. 2012 Mar;39(3):2843-9
pubmed: 21678055
J Pineal Res. 2011 Apr;50(3):250-60
pubmed: 21118301
Pancreas. 2011 Apr;40(3):410-4
pubmed: 21178648
Eur J Pharmacol. 2009 Mar 15;606(1-3):61-71
pubmed: 19374844
Cell Rep Med. 2020 Nov 17;1(8):100143
pubmed: 33294863
Nat Rev Cancer. 2012 Oct;12(10):685-98
pubmed: 23001348

Auteurs

Matias Estaras (M)

Departamento de Fisiología, Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, Avenida de Las Ciencias S/N, 10003, Cáceres, Spain.

Candido Ortiz-Placin (C)

Departamento de Fisiología, Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, Avenida de Las Ciencias S/N, 10003, Cáceres, Spain.

Alba Castillejo-Rufo (A)

Departamento de Fisiología, Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, Avenida de Las Ciencias S/N, 10003, Cáceres, Spain.

Miguel Fernandez-Bermejo (M)

Departamento de Gastroenterología, Hospital Universitario, Cáceres, Spain.

Gerardo Blanco (G)

Unidad de Cirugía Hepatobiliopancreática Y Transplante Hepático, Hospital Universitario, Badajoz, Spain.

Jose M Mateos (JM)

Departamento de Gastroenterología, Hospital Universitario, Cáceres, Spain.

Daniel Vara (D)

Departamento de Gastroenterología, Hospital Universitario, Cáceres, Spain.

Pedro L Gonzalez-Cordero (PL)

Departamento de Gastroenterología, Hospital Universitario, Cáceres, Spain.

Sandra Chamizo (S)

Departamento de Gastroenterología, Hospital Universitario, Cáceres, Spain.

Diego Lopez (D)

Unidad de Cirugía Hepatobiliopancreática Y Transplante Hepático, Hospital Universitario, Badajoz, Spain.

Adela Rojas (A)

Unidad de Cirugía Hepatobiliopancreática Y Transplante Hepático, Hospital Universitario, Badajoz, Spain.

Isabel Jaen (I)

Unidad de Cirugía Hepatobiliopancreática Y Transplante Hepático, Hospital Universitario, Badajoz, Spain.

Noelia de Armas (N)

Unidad de Cirugía Hepatobiliopancreática Y Transplante Hepático, Hospital Universitario, Badajoz, Spain.

Gines M Salido (GM)

Departamento de Fisiología, Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, Avenida de Las Ciencias S/N, 10003, Cáceres, Spain.

Juan L Iovanna (JL)

Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique Et Technologique de Luminy, Marseille, France.

Patricia Santofimia-Castaño (P)

Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique Et Technologique de Luminy, Marseille, France.

Antonio Gonzalez (A)

Departamento de Fisiología, Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, Avenida de Las Ciencias S/N, 10003, Cáceres, Spain. agmateos@unex.es.

Articles similaires

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis
Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

Lisa Demoen, Filip Matthijssens, Lindy Reunes et al.
1.00
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Animals Mice Humans Cell Line, Tumor
Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria

Classifications MeSH